We’re proud to be attending the 6th Annual Liver Connect Conference, a leading forum dedicated to advancing liver disease care through collaboration, innovation, and clinical excellence.
Attending? Let’s connect and explore how we can drive greater impact together.
#Perspectum #LiverConnect
In what may be a case of saving the best for last (out of a fantastic @CLDFoundation #liverconnect meeting), @NoureddinMD with a tour de force covering #MASH from NITs to how to select appropriate #rezdiffra patients to measured optimism about the future #livertwitter
@livermama1 with concluding remarks. @CLDFoundation #liverconnect meeting is growing and will be happening around the same time next year. #livertwitter
Fantastic @CLDFoundation #liverconnect session on autoimmune liver disease @lilydaramd @autoimmuneliver @rajVuppaLanchi @clbowlus @AparnaGoelMD @craiglammertIU #livertwitter
@DrLoomba on NITs in #MASH
@CLDFoundation #liverconnect
#livertwitter
@CLDFoundation #liverconnect is now established as a premier hepatology meeting with fantastic educational offerings in #HCV #HDV #HDV #HCC #PBC #MASLD #MASH and many more topics. Congrats to the board of directors on a wonderful program
Thank you @CLDFoundation for another wonderful edition of #liverconnect I certainly learned a lot and had a lot of fun doing it. Already looking forward to next year!
Truly a highlight of @CLDFoundation #liverconnect meeting is the #HBV session discussing therapies and strategies for functional cure with Profs. Adam Ghering @UHN Jorg Petersen Ira Jacobsen and MF Yuen #LiverTwitter
@OHIOLIVER is strongly represented at #liverconnect with our board president @pgholam and our treasurer @guts44 #livertwitter #GITwitter
It’s 40 and windy in the OC but the sun has finally made an appearance @CLDFoundation #liverconnect #livertwitter
@CLDFoundation @Duke_liverdoc @Duke_GI_ not all lean “NAFLD” is garden variety. Look for other less common causes of steatosis @CLDFoundation #liverconnect
@Duke_liverdoc @Duke_GI_ “lean” #NAFLD is a significant proportion of all NAFLD in Asia. @CLDFoundation #liverconnect
@AlinaAllenMD @MayoClinicGIHep states the painful obvious…we need to do better. @CLDFoundation #CLDF #liverconnect
@AlinaAllenMD @MayoClinicGIHep Hispanics at very high risk for #NAFLD and #NASH Hispanic, diabetic women with BMI>30 have greater than 90% likelihood of NAFLD #@CLDF #liverconnect
We are live from Scottsdale for day 1 of @CLDFoundation #liverconnect meeting.